Thanks for your answers ChickenNuggets. The extra info helped.
My views on the link between ARR and revenue in the following half year:
- Based on my detailed analysis of a similar early-stage growth company (NEA), I have found that their Group Revenue in the half following their published ACV (Similar to ARR) is typically 52% - 55% of that figure. So, if that applied to DUB, revenue (excluding grants) would be around $5.7M for the current half year.
- DUB could be different if it takes longer to get payment under their contracts (e.g. due to slow payment terms by the big telecom companies). But I don't think it would be much different. Hence my revenue estimate of $5.5M for the current half in my last post.
To estimate revenue for the second half of calendar 2020, we need to estimate the growth rate. I have assumed around 36% in that six months, hence my second half revenue of $7.5M for total calendar year revenue of $13M. That could be conservative based on past growth rates.
P.S. If you appreciate my response to your questions, could you show that by giving an upvote?
- Forums
- ASX - By Stock
- Ann: Quarterly Update & Appendix 4C
Thanks for your answers ChickenNuggets. The extra info helped.My...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DUB (ASX) to my watchlist
|
|||||
Last
4.1¢ |
Change
-0.001(2.38%) |
Mkt cap ! $37.67M |
Open | High | Low | Value | Volume |
4.2¢ | 4.4¢ | 4.1¢ | $66.52K | 1.579M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1081451 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 447211 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1081451 | 0.041 |
4 | 785000 | 0.040 |
3 | 292589 | 0.039 |
3 | 313421 | 0.038 |
4 | 1608567 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 447211 | 1 |
0.044 | 4139 | 1 |
0.045 | 125000 | 3 |
0.046 | 25000 | 2 |
0.047 | 39000 | 3 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
DUB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online